Clinical trial
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in…
NCT00337558 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00337558 |
|---|---|
| Title | A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) |
| Official title | Solifenacin Succinate in a Flexible Dose Regimen With Simplified Bladder Training Versus Solifenacin Succinate in a Flexible Dose Regimen Alone in a Prospective, Randomized, Parallel Group, Overactive Bladder Symptom Study |
| Acronym | SOLAR |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Europe B.V. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Overactive Bladder, Urinary Incontinence, Urge Incontinence |
| Intervention type | Behavioral, Drug |
| Interventions | Solifenacin succinate, Simplified bladder training |
| Enrollment | 643 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 16, 2006 |
| Last update posted | Sep 18, 2014 |
| Countries | Australia, Belgium, Czechia, France, Hungary, Italy, Netherlands, Poland, Russia, Spain, Turkey (Türkiye) |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: